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A VSG Expression Site±Associated Gene
Confers Resistance to Human Serum
in Trypanosoma rhodesiense
specificity. T.b. brucei causes ªnaganaº in cattle but is
not pathogenic in humans because this subspecies is
lyzed by haptoglobin-related proteins associated with a
subfraction of high-density lipoproteins (HDL) in human
serum (reviewed in Tomlinson and Raper, 1998). T.b.
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Belgium when ETat 1.10 was eliminated by homologous antisera.
Moreover, ETat 1.10 has never been obtained in the S
form. Despite the requirement of ETat 1.10 for resis-
tance, the VSG per se was not important, since clonesSummary
derived from ETat 1.10 and expressing other VSGs, for
instance ETat 1.2, were found in both R and S formsInfectivity of Trypanosoma brucei rhodesiense to hu-
(Van Meirvenne et al., 1976). Thus, while in the ETat 1mans is due to its resistance to a lytic factor present
strain resistance is linked to antigenic variation it doesin human serum. In the ETat 1 strain this character
not depend on the VSG. This phenomenon may be re-was associated with antigenic variation, since expres-
sion of the ETat 1.10 variant surface glycoprotein was lated to the structure of the transcription unit of the VSG.
required to generate resistant (R) clones. In addition, This unit, located in a telomeric expression site (ES), is
in this strain transcription of a gene termed SRA was polycistronic and contains several genes, termed ESAGs
detected in R clones only. We show that the ETat 1.10 for expression site±associated genes, in addition to the
expression site is the one selectively transcribed in VSG (Cully et al., 1985; Kooter et al., 1987; Pays et al.,
R variants. This expression site contains SRA as an 1989). Approximately 20 different ESs can be used alter-
expression site±associated gene (ESAG) and is char- natively for VSG expression (Navarro and Cross, 1996).
acterized by the deletion of several ESAGs. Transfec- Antigenic variation occurs through transcriptional switch-
tion of SRA into T.b. brucei was sufficient to confer ing between ESs, a process termed in situ (in)activation,
resistance to human serum, identifying this gene as or gene conversion targeted to the VSG (for recent re-
one of those responsible for T.b. rhodesiense adapta- views, see Borst et al., 1998; Cross et al., 1998; Pays
tion to humans. and Nolan, 1998). These properties provide a possible
explanation for the antigenic variation-linked resistance
Introduction to NHS in T.b. rhodesiense, in which the gene responsi-
ble for resistance would be an ESAG only present in
Trypanosoma brucei is the paradigmatic species of Afri- some ESs, namely the ETat 1.10 ES in the ETat 1 strain.
can trypanosomes, protozoan flagellate parasites trans- Switching to this site would confer resistance, which
mitted by tsetse flies. These organisms are particularly could be conserved in clones derived from ETat 1.10
well studied for their spectacular mechanism of anti- provided antigenic variation does not result from a
genic variation, a process by which the major surface switch of ES but is performed by gene conversion only
antigen, the variant surface glycoprotein (VSG), is con- replacing the VSG gene by another in the same ES.
tinuously changed to escape the immune defenses of In the ETat 1 strain, differential cDNA screening be-
the mammalian host (Cross, 1978). T. brucei consists of tween S and R clones identified a transcript present
three subspecies that are indistinguishable by conven- only in R forms (De Greef et al., 1989). The gene for this
tional morphological, biochemical, and antigenic criteria transcript, termed SRA for serum resistance-associ-
but differ by their geographical distribution and host ated, was found to encode a VSG-like protein (De Greef
and Hamers, 1994). In this study, we show that SRA is
an ESAG of the ETat 1.10 ES, in agreement with the§ To whom correspondence should be addressed (e-mail: epays@
hypothesis presented above. Moreover, SRA was founddbm.ulb.ac.be).
‖ These authors contributed equally to this work. to confer resistance to NHS when transfected into T.b.
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Figure 1. Pedigree of the T.b. rhodesiense ETat 1 R and S Clones
TREU164 is a stabilate obtained after 21 passages in mice and rats,
from a tsetse fly captured in Uganda in 1960. The parasite symbol
depicts the cloning of trypanosomes, and NHS indicates that a
treatment with human serum was performed before and during injec-
tion into mice. In order to select antigenically distinct R clones from
ETat 1.10R, selective elimination of ETat 1.10 was accomplished by
lytic neutralization with homologous antiserum.
brucei. Therefore, the antigenic variation-linked expres-
sion of SRA appears to underly resistance to human
serum in at least some strains of T.b. rhodesiense.
Results
Antigenic Variation-Linked Switching from
Sensitivity to Resistance in ETat 1
In the ETat 1 strain of T.b. rhodesiense, the selection of
R clones systematically resulted in the expression of
the ETat 1.10 VSG, and counter-selection was necessary
in order to generate R clones expressing different VSGs
(Van Meirvenne et al., 1976). The genetic events underly-
ing these phenomena were studied in cloned variants
whose pedigree is shown in Figure 1. An ETat 1.2S clone
was derived from the initial stabilate (2BS) and com-
pared with two other clones expressing the same VSG,
respectively, in R form derived from ETat 1.10R and in S
form derived from the R form (2CR and 2CS). Additional
clones in R and S forms were included in this study,
Figure 2. Genetic Events Underlying Antigenic Variation
such as ETat 1.8R and 1.8S, both of which were obtained
(A±C) Results of Southern blot hybridization with the indicated
independently (Figure 1). Figures 2±4 depict the genetic probes, whose size is represented by thick bars under the maps in
characteristics of the series 2BS-10R-2CR-2CS fol- Figure 4B. In (A), the genomic DNAs were digested with EcoRI.
lowed by 8R and 8S, in this order. Where indicated, increasing amounts of pancreatic DNAase I were
added to isolated nuclei prior to DNA extraction (Pays et al., 1981).
(C) Results of chromosomal PFGE analysis, an ethidium bromideMechanisms of Antigenic Variation in the ETat
staining of the gel being shown at the left. (D) summarizes the results.1.10R-2CR-2CS Clone Derivation
In the ES maps, the flag represents the active transcription promoter,
The ETat 1.10R, 1.2CR, and 1.2CS VSG cDNAs were the boxes represent genes, and the terminal vertical bar depicts the
cloned to generate hybridization probes. The ETat 1.2CR chromosome end.
and 1.2CS cDNAs were found to be identical. In the ETat
1.2BS clone, the ETat 1.10 probe hybridized with three
DNA fragments (Figure 2A, first lane). In ETat 1.10R, directly derived from ETat 1.10R (third lane of left panel),
suggesting that gene conversion associated with anti-despite the antigenic variation event leading to expres-
sion of ETat 1.10, no difference was observed in this genic variation led to the replacement of this gene by
the copy (ELC, for expression-linked copy) of ETat 1.2.pattern (second lane). The absence of DNA rearrange-
ment suggested that ETat 1.10 was activated in situ, The loss of ETat 1.10 was also observed in Etat 1.8R
(fifth lane) and in other R clones obtained independentlythrough ES switching. The active ETat 1.10 gene was
contained in a 6 kb EcoRI fragment, since this fragment by neutralization of ETat 1.10 with specific antibodies
(data not shown).was hypersensitive to DNAaseI (Figure 2A, arrowhead).
Interestingly, this gene was lost in ETat 1.2CR, a clone In the ETat 1.2BS clone ETat 1.2 was present as two
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Figure 3. R-Linked Transcription of the SRA
Gene
The indicated probes were hybridized with
Northern blots of total RNA (4 mg) from the
different T.b. rhodesiense clones (2BS, 10R,
2CR, and 2CS) and from T.b. brucei AnTat
1.3A (1.3), as well as with T.b. brucei trans-
formants (T1 and T2, two independent SRA
transformants; T0, control transformant). Ex-
posure time was 1 hr, 8 hr, and 4 days for the
VSGs, SRA, and actin probes, respectively,
except in the T1, T2, and T0 SRA lanes where
exposure was for 20 hr. The significance of
the two upper SRA transcripts in T1 and T2
is unclear, although the middle one may cor-
respond to dicistronic SRA-HygroR mRNA.
HindIII fragments (Figure 2B, left panel, first lane). In ETat primers specific to ESAG 7/6, which allowed the discrim-
ination between the different ES transcripts (data not1.10R (second lane) the size of these fragments was
altered, indicating a telomeric location, which was con- shown). Overall these results suggested that activation
of the ETat 1.10 ES is required to generate R clones andfirmed by genomic mapping (data not shown). A HindIII
1 HpaI digest revealed the presence of a HpaI site down- that in the absence of NHS the ETat 1.10 ES is counter-
selected.stream from the gene in one of the two copies (bottom
band in second panel). Expression of the ETat 1.2 gene
in ETat 1.2CR was linked to the appearance of a third In These Clones, Transcription of SRA Is Associated
with Resistance to Human SerumHindIII fragment, which migrated as a smear (Figure 2B,
third lane of first panel and third panel, arrowhead) but In accordance with previous results (De Greef et al.,
1989), SRA transcripts were only detected in R and notwas more clearly evidenced by the doubling of the hy-
bridization intensity of the 1 kb HindIII-HpaI fragment. in S clones (Figure 3). The detection of SRA transcripts
in 2CR but not in 2CS was especially significant, sinceThis smear is typical of actively transcribed telomeric
DNA (Pays et al., 1983), suggesting that the additional the latter clone was directly derived from the former and
expressed the same VSG. The level of SRA mRNA wasfragment contains the active ETat 1.2 ELC. This was
confirmed by the DNAase I sensitivity assay, which approximately one-eighth that of the VSG mRNA, both
being much more abundant (30- and 250-fold, respec-showed that this fragment was more sensitive than the
two others (third panel, arrowhead). Thus, in the ETat tively) than transcripts from housekeeping genes such
as actin.1.2CR clone, activation of ETat 1.2 was due to gene
conversion. According to this interpretation, in 2CR the
ETat 1.2 ELC replaced ETat 1.10. This was verified by The SRA Gene Is Contained in the ETat 1.10 ES
As shown in Figure 4A, the SRA probe hybridized withchromosomal DNA analysis. The ETat 1.10 probe hybrid-
ized to several chromosomes, one of which (approxi- several genomic fragments, the largest of which exhib-
ited the characteristics of telomeric DNA, including ex-mately 1.6 Mb) contained the copy lost in 2CR and thus
harbored the active ETat 1.10 ES (Figure 2C). In clone tensive terminal size variation (arrows and arrowheads
in second panel). Significantly, this fragment also ap-2CR the ETat 1.2 ELC mapped to the same chromosome,
since the intensity of labeling was increased 2-fold in this peared to hybridize with the ETat 1.10 probe except
in variants where the active ETat 1.10 gene was lostband in 2CR compared to 10R (Figure 2C, arrowhead).
Therefore, in 2CR the ETat 1.2 ELC replaced the active following gene conversion (first panel, arrows). These
observations strongly suggested that the telomeric SRAETat 1.10 gene in the same ES. Finally, in clone ETat
1.2CS the additional ETat 1.2 fragment was no longer fragment contained the ETat 1.10 ES. Moreover, in the
2CR and 2CS clones where the ETat 1.10 gene was lost,diffuse (Figure 2B, fourth lane of first panel), suggesting
transcriptional inactivation, which was confirmed using the telomeric SRA fragment (19 kb) hybridized with the
ETat 1.2 probe and clearly this fragment contained theDNAase I (fourth panel, arrowhead). In this clone the
upper band became the most sensitive to DNAase I, ETat 1.2 ELC (third panel, arrowheads). DNAase I sensi-
tivity analysis also supported the colocalization of SRAindicating that the switch from 2CR to 2CS was due to
in situ activation. and ETat 1.2 ELC within the very same fragment (data
not shown). Therefore, an SRA copy is linked to theThese data are summarized in Figure 2D. In ETat
1.10R, in situ activation of the ETat 1.10 ES occurred. active VSG in R clones only. This conclusion was in
agreement with the colocalization in a 1.6 Mb chromo-In ETat 1.2CR, VSG switching in the presence of NHS
was due to gene conversion resulting in the replacement some of SRA and both VSGs expressed in R clones
(Figure 2C).of ETat 1.10 by the ELC synthesized on one of the two
telomeric ETat 1.2 copies. In the absence of NHS, in The restriction maps of the ETat 1.10R and ETat 1.2CR
ESs are presented in Figure 4B. Two large regions, im-situ activation allowed the reexpression of the ETat 1.2
ES already functional in the 2BS clone. As a conse- mediately upstream and downstream from the VSGs,
appeared to be devoid of restriction sites. These regionsquence, the previously active ETat 1.2 ELC was con-
served but silent (ex-ELC) in the ETat 1.10 ES. These probably contain arrays of 76 bp repeats (ªbarrenº re-
gion) and telomeric repeats, respectively (Bernards etconclusions were confirmed by RT-PCR using pairs of
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peats typical of VSG ESs (Bernards et al., 1985) (Figure
5). Upstream from these repeats, the sequence was
virtually identical to that found downstream from ESAG
5 in the AnTat 1.3A ES, starting precisely in the single
76 bp repeat-related element located approximately 840
bp downstream from the stop codon of ESAG 5 (dotted
underline in Figure 2 of Pays et al., 1989). These results
confirmed the location of an SRA copy in a VSG ES. As
expected from this location, the sequence of the SRA
cDNA was identical to that of the gene present in the
ES, and SRA transcription fully resisted a-amanitin
(Kooter and Borst, 1984) (data not shown).
The ETat 1.10 ES Is Severely Truncated
In order to characterize completely the ETat 1.10R/
1.2CR ES, an inverse PCR strategy was employed (steps
2 and 3, see Experimental Procedures and scheme in
Figure 5). A 4 kb fragment was amplified after EcoRV
digestion of the genomic DNA from the ETat 1.2CR
clone, followed by self-ligation and priming with the ETat
1.2-specific P121 oligonucleotide employed previously,
together with different oligonucleotides specific to the
region immediately downstream from the 59-terminal
BamHI site of the fragment initially cloned. Sequence
analysis of this 4 kb fragment showed that it was virtually
identical to the ESAG 5 region of the AnTat 1.3A ES
Figure 4. Localization of an SRA Copy in R-VSG ESs (Figure 5). The ETat 1.2CR ES was subsequently cloned
(A) Results of hybridization with BamHI 1 EcoRV digests of genomic to the promoter region by inverse PCR on HpaI-digested
DNAs. ETat 1.2CR genomic DNA, using proximal primers orien-
(B) Restriction maps of the VSG ESs in the two R clones, as deter- tated toward the 59-EcoRV and 39-HpaI sites of the previ-
mined from Southern blot analysis. The thick bars under the maps
ous cloned fragment (step 3, see Experimental Proce-represent the probes used in this and other figures, except that the
dures) This region of the ETat 1.2CR ES was also veryETat 1.2 probe used in this figure is shown as a hatched bar. In the
similar to the AnTat 1.3A ES except that the RIME ret-ETat 1.2CR ES map, the arrows designate the two BamHI sites used
for inverse PCR using the pairs of primers indicated by arrowheads, roposon (see Pays et al., 1989) was missing and the two
and the thick line highlights the BamHI-HpaI fragment cloned as a genes encoding the subunits of the transferrin receptor,
result of this PCR (step 1 in Figure 5). A, ApaI; Ba, BamHI; E, EcoRI; ESAG 6 and ESAG 7, were not in the same order (FigureH, HindIII; Hp, HpaI; P, PstI; Sm, SmaI; V, EcoRV.
5). As expected, the nucleotide sequence in the ªhyper-
variableº region of ESAG 6 was found to be identical to
that determined by RT-PCR on both ETat 1.10R and
ETat 1.2CR RNAs, but different from that found by RT-al., 1985; Kooter et al., 1987; Pays et al., 1989). As ex-
PCR on both ETat 1.2BS and ETat 1.2CS RNAs (datapected, in these ESs an SRA copy was present immedi-
not shown). These results clearly confirmed the correctately upstream from the barren region, and this gene
identification of the cloned sequences.was not detected in the ESs transcribed in the ETat 1.2S
The cloned ETat 1.10/1.2CR ES was strikingly shorterclones (data not shown). Finally, the restriction maps of
than the AnTat 1.3A ES and totally lacked the 20 kbthe upstream environment of SRA in the ETat 1.10R and
region containing ESAG 4, ESAG 8, ESAG 3, ESAG 2,ETat 1.2CR ESs appeared to be similar. Based on these
and ESAG 1. Moreover, analysis by PCR demonstratedresults, we attempted to clone DNA fragments con-
that none of these ESAGs was located downstream fromtaining both SRA and VSG. Due to the presence of a
SRA, a result consistent with the fact that this regionlarge intervening region of repeats that prevented direct
lacked restriction sites. In addition, both Northern blotcloning, a special strategy was devised. In the ETat
hybridization and run-on transcription assays confirmed1.2CR ES two BamHI sites, arrowed in Figure 4B, were
the absence of transcription of ESAGs 4, 8, 3, 2, and 1conveniently located for this purpose. The 59-site was
in clone ETat 1.2CR, whereas the transcription of thesemapped approximately 3 kb upstream from SRA, whereas
genes was clearly detected in clone ETat 1.2CS (datathe 39-site was present in the VSG. The ETat 1.2CR gDNA
not shown). These data indicated that the VSG ES tran-was digested with BamHI, then ligated and subjected to
scribed in R clones differs drastically from the ªusualºinverse PCR using as pairs of primers the oligonucleo-
one (either T.b. brucei AnTat 1.3A or T.b. rhodesiensetides shown by arrowheads in the ETat 1.2CR ES map
ETat 1.2CS) in the number of ESAGs. It is probable that(Figure 4B). As expected from the map, a fragment of
the deletion characterizing the ETat 1.2CR ES resulted3.7 kb containing approximately 3.2 kb upstream from
from homologous recombination between 76 bp repeatsSRA was obtained. The nucleotide sequence of this
region indicated that SRA was preceded by 76 bp re- flanking the ESAG 4 to ESAG 1 region.
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Figure 5. Comparison of the ETat 1.2CR and AnTat 1.3A ESs
The map summarizing the cloning and sequencing of the ETat 1.2CR ES is shown at the bottom, with indication of the primers used (arrowheads)
and products obtained (thick lines) during the three successive steps of inverse PCR. This map is compared with that of the AnTat 1.3A ES
(Pays et al., 1989), where the arrow indicates the transcription start site and the boxes represent the VSG and ESAGs 1±8 as indicated by
numbers, as well as the RIME retroposon (R).
Direct Evidence for the Involvement of SRA the ETat 1.2CS clone (data not shown), but the SRA
transformants were not affected even after 22 hr (Figurein Resistance to NHS
The possible involvement of SRA in resistance to NHS 6). After 2 days of in vitro cultivation in the presence
of 5% NHS, both control and SRA transformants werewas evaluated by targeting of this gene into the ribo-
somal locus of T.b. brucei procyclic forms by homolo- injected into mice. Even small inoculates equivalent to
1,000 parasites from the SRA transformants led to infec-gous recombination. The AnTat 1 strain was chosen
because it was never found resistant to NHS despite tion that was clearly detectable after 4 days, whereas
an inoculate from the control corresponding to 100,000intense studies in different laboratories, and it does not
contain SRA (data not shown). The insect-specific pro- parasites at the beginning of the in vitro incubation did
not lead to infection even 2 weeks after injection. Thecyclic forms were used because they are very easy to
transfect, as opposed to pleomorphic bloodstream transformants were also treated with undiluted NHS as
described by Van Meirvenne et al. (1976). Under theseforms. The plasmid construct used for transfection con-
tained a gene encoding resistance to hygromycin to conditions the same differential lysis between the con-
trol and SRA transformant was observed, except thatselect the trypanosome transformants. Two indepen-
dent SRA transformants were generated that contained complete lysis of the control occurred after only 3 hr.
After 5 hr in the presence of undiluted NHS, the trans-either a single or a few integrated copies of the construct
(data not shown). As a control, the same targeting was formant trypanosomes were injected into mice, and re-
sults similar to those observed in the case of treatmentperformed with an identical construct, but lacking SRA.
Cyclical transmission in tsetse flies allowed the genera- with 5% NHS were obtained. In order to evaluate the
resistance to NHS in vivo, the transformant trypano-tion of bloodstream form transformants. Transcription
of SRA was detected in these SRA transformants, with somes were injected into mice and when the parasitae-
mia reached about 106 parasites per milliliter (arounda mRNA longer than the wild type (2.1 kb instead of 1.5
kb) due to the presence of the 39-UTR and polyadenyla- day 4), the animals were injected with 0.5 ml of NHS.
The ETat 1.2CR and 1.2CS clones, as well as the T.b.tion signal of b-tubulin downstream from SRA (Figure
3). The level of this mRNA was about one-fifth that of brucei AnTat 1.1 clone, were used as controls. While
the injection of NHS appeared to ablate the infection bythe SRA mRNA in ETat 1.10R.
The resistance to NHS of the SRA and control trans- both the ETat 1.2CS and AnTat 1.1 clones, as well as
by the control transformant (no detectable parasitaemiaformants was measured in vitro and in mice. The pres-
ence of 5% NHS in vitro induced the lysis of the control from the day following the injection to 1 week later in
the case of ETat 1.2CS, and apparently definitely in thetransformants after 10 hr, exactly as for most cells of
Cell
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Discussion
As predicted from serological studies (Van Meirvenne
et al., 1976), our data indicate that in the ETat 1 strain
of T.b. rhodesiense the ETat 1.10 ES needs to be acti-
vated to obtain resistance to NHS. At least in the clone
derivation that we studied, antigenic variation still al-
lowed resistance provided the same ES was used,
strongly suggesting that the genetic determinant for re-
sistance is encoded in this site but is not the VSG. Evi-
dence obtained from genomic DNA restriction mapping,
cloning, run-on transcription, and RNA analysis indi-
cated that SRA is an ESAG present only in this particular
ES, in keeping with the identification of SRA mRNA as
a transcript associated with resistance (De Greef et al.,
1989). Transfection of SRA into T.b. brucei was neces-
sary and sufficient to confer NHS resistance, demonstra-
ting that antigenic variation-associated expression of
this particular gene can confer adaptation of ETat 1 to
humans.Figure 6. Tranfection of SRA into T.b. brucei Confers Resistance to
NHS
SRA Is an ESAG of the ETat 1.10 EST.b. brucei AnTat 1 parasites transfected with either a control plas-
Despite the presence of a very large SRA family, only amid (pTSARib) (dots) or PTSARibSRA (squares; two independent
transformants gave identical results) were incubated at a final con- single member was found to be transcribed. As SRA
centration of approximately 105 cells/ml in HMI-9 medium (Hirumi encodes a VSG-like protein (De Greef and Hamers,
and Hirumi, 1989) at 378C, in the presence (black symbols) or ab- 1989), this observation may arise because most SRA
sence (open symbols) of 5% NHS. Under these cultivation condi-
copies could be clustered with the majority of VSGs intions, while monomorphic parasites such as the ETat 1.2CS and
long arrays of transcriptionally silent sequences (Van1.2CR clones grew exponentially without lag period (data not
der Ploeg et al., 1982). The close association of an SRAshown), pleomorphic trypanosomes such as those studied here did
not proliferate within several days. copy with a ETat 1.2 copy in a silent 3.5 kb BamHI-
EcoRV fragment supports this hypothesis. In addition,
SRA appeared to be present in a single ES, despite the
existence of approximately 20 ESs in the trypanosomecases of AnTat 1.1 and the control transformant), the
genome (Navarro and Cross, 1996). A similar arrange-infection with the SRA transformants was unaffected
ment, a VSG pseudogene that is embedded in the arrayand reached high levels (107 to 108 parasites per milliliter)
of 76 bp repeats preceding the VSG, has been reportedin the next 2 to 3 days, similar to that observed with ETat
for the 221 VSG ES (Bernards et al., 1985). This organiza-1.2CR. As expected from their virulence characteristics,
tion may not be uncommon and probably results fromthe pleomorphic SRA transformants developed a 3 to
antigenic variation-linked recombinations occurring in4 week parasitaemia until the mice died of infection,
this region of the VSG ES.whereas the monomorphic ETat 1.2CR clone caused
the death of the mice after 5 days. These results indi-
cated that resistance of the SRA transformants to NHS
Selective Activation of the ETat 1.10 ES in R Clonesnot only occurred in vitro, but also in vivo. We conclude
In the ETat 1 strain the ETat 1.10 ES was activated whenthat expression of SRA was necessary and sufficient to
trypanosomes were confronted with human serum,confer NHS resistance to T. brucei.
while a spontaneous switching to S forms was observed
when NHS was removed, even if the VSG remained the
same (Van Meirvenne et al., 1976; this study). Thus, in theExpression of SRA
SRA encodes a VSG-like protein, unusually short and absence of selective pressure the R phenotype seems to
be counter-selected. Since this phenotype results fromapparently devoid of N-terminal signal peptide (De Greef
and Hamers, 1994). Despite the generation of several a defect in the uptake of the lytic factor bound to a
surface receptor (Hager and Hajduk, 1997), it may bedifferent specific antibodies, both poly- and mono-
clonals and from mammals and chicken, the detection hypothesized that R clones also do not process other
HDL-associated components, which could constitute aof this protein in R clones remained inconclusive (data
not shown). In order to evaluate whether the absence selective disadvantage. Moreover, the ETat 1.10 ES
lacks several ESAGs, whose function might also be im-of signal peptide accounts for the lack of detection as
well as for the biological effect of SRA, we constructed portant for growth. However, in vitro no difference in
growth was observed between ETat 1.2CR and 1.2CSa chimeric gene encoding SRA fused to the sequence
for the N-terminal signal peptide of the AnTat 11.17 VSG (data not shown), suggesting that neither the lack of
uptake of other HDL components nor the absence of(Do Thi et al., 1991). Transfection of this construct into
T.b. brucei conferred resistance to NHS exactly as the expression of ESAGs 1, 2, 3, 4, and 8 are required under
these conditions. The nonessential character of ESAGwild-type SRA, and the chimeric SRA protein was still
undetectable (data not shown). 1 was already noted (Carruthers et al., 1996). As is also
Resistance to Human Serum in Trypanosomes
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except that the ETat 1.2CR gDNA was digested with EcoRV beforethe case of ESAG 4, this may be due to the simultaneous
self-ligation, and the primers for PCR were P121 and either ESRA1expression of many homologous genes, termed GRE-
(59CCATCACTTCTATTGCCGCCCC39) or ESRA2 (59GATGATACTTTSAGs, in other genomic loci (Pays et al., 1989; Morgan
TGCTGCCGCCAC39), both designed based on the sequence ob-
et al., 1996). tained in step 1. PCR conditions were the same as above except
that the annealing temperature was 658C. A unique fragment of
about 4.5 kb was obtained, blunt-ended, and subcloned for fullSRA Leads to Resistance to NHS
sequencing. In step 3, the ETat 1.2CR gDNA was digested with HpaIThe clear phenotype observed upon transfection of SRA
before self-ligation. The primers for PCR were ESRA6B (59CTGTTACinto T.b. brucei indicates that SRA is expressed. At this
GCCATTATTACCAGC39) and ESRA7B (59AATCAGGCTTTTACCGC
point we can only speculate on how this expression CGTC39), which were designed based on the sequence obtained in
confers resistance. The lack of detection of the SRA step 2, including a 39-nucleotide specific to the ETat 1.2RC ES as
protein strikingly contrasts with the very high level of determined by the comparison with known ES sequences. PCR
conditions were the same as above except that the annealing tem-the mRNA, suggesting serious problems at the level of
perature was 578C. A unique fragment of about 6.5 kb was obtained,translation and/or processing of the protein. Our results
blunt-ended, and subcloned for full sequencing.suggest that these problems are not due to the absence
The plasmid used for targeting SRA into T.b. brucei was con-
of N-terminal signal sequence in SRA. The presence structed by first replacing the procyclin promoter present in pTSA-
of SRA transcripts, aberrant trafficking of SRA, and/ HYG2 (635 bp Asp718-XhoI fragment) (Sommer et al., 1992) with a
or accumulation of SRA degradation products could 2 kb HindII fragment encompassing the T. brucei rDNA promoter,
then reintroducing the procyclin splice site (290 bp SpeI fragment)interfere with the uptake of the lytic factor and/or its
downstream from this promoter (in HindIII of pTSA-HYG2), generat-action within the cell. Since the thioprotease inhibitor
ing pTSA-Rib. The SRA open reading frame, preceded or not by theleupeptin inhibits, at least partially, trypanolysis by NHS
sequence of the N-terminal signal peptide of the AnTat 11.17 VSG
(Hager et al., 1994), it may be envisaged that SRA pep- (Do Thi et al., 1991), was PCR-amplified from the cDNA (De Greef
tides mimic the effect of leupeptin. These hypotheses et al., 1989) with flanking XhoI and BglII sites, subcloned in a plasmid
are currently under investigation. termed pEST to allow insertion, immediately downstream from the
gene, of a 0.83 kb BamHI-BglII fragment containing the 39-UTR and
polyadenylation site of T. brucei b-tubulin mRNA, then the 2.2 kbGenerality of These Observations
SRA-containing XhoI-BglII fragment was inserted between the XhoI
So far the results described here were confirmed in three and BamHI sites located downstream from the rDNA promoter of
other strains of T.b. rhodesiense (AnTAR 25, TRZ, and pTSARib, generating pTSARib-SRA. The plasmids were linearized
ITMAS221088). However, they may not apply to all cases with SphI before electroporation. The correct insertion into the rDNA
promoter locus was checked by Southern blot analysis (data notof trypanosome resistance to NHS. First, R clones lack-
shown).ing SRA mRNA have been reported in T.b. rhodesiense
(Rifkin et al., 1994). Second, T.b. gambiense lacks SRA
(De Greef et al., 1989). The elucidation of the mechanism Acknowledgments
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